Comprehensive CV Disease Management : From Fundamentals to Innovation

Comprehensive CV Disease Management : From Fundamentals to Innovation is organized by Cleveland Clinic Foundation and would be held on Feb 10, 2017 at Sheraton Mahwah Hotel, Mahwah, New Jersey, United States of America.

The target audience for this medical event for practicing clinical cardiologists, cardiac surgeons, electrophysiologists, neurologists; primary care, family practice and internal medicine physicians with an interest in cardiology. This CME Conference has been approved with a maximum of 7 AMA PRA Category 1 Credits.

Conference Objectives :
• Assess current recommendations and therapies for the treatment of dyslipidemia, including its management in statin intolerant patients
• Review the latest evidence and guideline recommendations on achieving optimal blood pressure levels
• Apply recent evidence and guideline recommendations on glucose-lowering agents for the prevention of cardiovascular (CV) events and mortality in type II diabetes
• Relate how imaging modalities contribute to risk stratifying patients for coronary artery disease (CAD)
• Understand the latest advances in interventional cardiology, including bioresorbable scaffolds in the treatment of CAD, and cardiothoracic surgery, including new techniques for valve repair and replacement
• Appreciate how the diabetes epidemic impacts cardiac surgery strategies to improve long-term survival
• Review the evolving indications, techniques, and outcomes for surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR), and mitral valve repair/replacement
• Discuss contemporary catheter ablation strategies for the treatment of atrial fibrillation (AF)